Abstract
We recently reported that according to patients and healthcare professionals in breast cancer and nephrology trials, teams conducting the trials got their choice of primary outcome wrong (72% of the time) more often than they got it right (28% of the time). A Patient and Public Involvement (PPI) representative, co-author of this letter, asked (on Twitter) whether PPI contributors had been involved in the design of the original trials and by extension the outcome selection. The purpose of this study was to answer this question.
Original language | English |
---|---|
Article number | 93 |
Number of pages | 5 |
Journal | Trials |
Volume | 24 |
Issue number | 1 |
Early online date | 7 Feb 2023 |
DOIs | |
Publication status | Published - 7 Feb 2023 |
Bibliographical note
AcknowledgementsWe would like to acknowledge our PPI colleagues on Twitter who read and commented on our work, helping bring the importance of PPI in clinical trials to the fore.
Funding
There was no direct funding received for this research. The HRB CRF-C at UCC facilitated the placement of an undergraduate BSc Public Health Sciences student, CB, who led this study under supervision. The HRB Clinical Research Facility receives core funding from the Health Research Board, Ireland, and matched funding from University College Cork. The Health Services Research Unit, University of Aberdeen, receives core funding from the Chief Scientist Office of the Scottish Government Health Directorates.
Keywords
- Trial methodology
- methodology
- Clinical trials
- Patient and Public Involvement/PPI